Artiva Biotherapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | — | — | $102.8M |
| FY2023 | $50.7M | $105.1M | $53.5M |
| FY2024 | $22.9M | $209.6M | $40.2M |
| FY2025 | $21.0M | $130.9M | $26.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | — | — | $102.8M |
| FY2023 | $50.7M | $105.1M | $53.5M |
| FY2024 | $22.9M | $209.6M | $40.2M |
| FY2025 | $21.0M | $130.9M | $26.7M |